AngioDynamics Stock Price, News & Analysis (NASDAQ:ANGO)

$16.46 0.11 (0.67 %)
(As of 01/17/2018 04:00 PM ET)
Previous Close$16.35
Today's Range$16.32 - $16.56
52-Week Range$14.80 - $18.85
Volume193,500 shs
Average Volume354,300 shs
Market Capitalization$600.79 million
P/E Ratio-78.38
Dividend YieldN/A
Beta1.04

About AngioDynamics (NASDAQ:ANGO)

AngioDynamics logoAngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

Receive ANGO News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Supplies
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:ANGO
CUSIP03475V10
Phone518-795-1400

Debt

Debt-to-Equity Ratio0.17%
Current Ratio2.56%
Quick Ratio1.65%

Price-To-Earnings

Trailing P/E Ratio-78.3772201323746
Forward P/E Ratio23.86
P/E Growth1.57

Sales & Book Value

Annual Sales$349.64 million
Price / Sales1.73
Cash Flow$1.42 per share
Price / Cash11.60
Book Value$14.19 per share
Price / Book1.16

Profitability

Trailing EPS($0.21)
Net Income$5 million
Net Margins-2.27%
Return on Equity4.63%
Return on Assets3.43%

Miscellaneous

Employees1,250
Outstanding Shares36,740,000

AngioDynamics (NASDAQ:ANGO) Frequently Asked Questions

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) posted its quarterly earnings results on Thursday, January, 4th. The medical instruments supplier reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. The medical instruments supplier earned $86.70 million during the quarter, compared to the consensus estimate of $88.15 million. AngioDynamics had a negative net margin of 2.27% and a positive return on equity of 4.63%. The business's revenue was down 2.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.19 earnings per share. View AngioDynamics' Earnings History.

When will AngioDynamics make its next earnings announcement?

AngioDynamics is scheduled to release their next quarterly earnings announcement on Wednesday, March, 28th 2018. View Earnings Estimates for AngioDynamics.

Where is AngioDynamics' stock going? Where will AngioDynamics' stock price be in 2018?

5 Wall Street analysts have issued 1 year price objectives for AngioDynamics' shares. Their forecasts range from $16.00 to $21.00. On average, they anticipate AngioDynamics' stock price to reach $18.50 in the next twelve months. View Analyst Ratings for AngioDynamics.

What are Wall Street analysts saying about AngioDynamics stock?

Here are some recent quotes from research analysts about AngioDynamics stock:

  • 1. According to Zacks Investment Research, "AngioDynamics ended the second quarter of fiscal 2018 on a dismal note, missing the Zacks Consensus Estimates on both the counts. However, the company rides on the market’s positive response to Solero platform, especially within the Microwave Ablation space. AngioDynamics has been offering a broad spectrum of products which has helped widen its commercial opportunities. The company is also a leading player in the thrombolytic catheters space. The company boasts highly unique catheters like Uni-Fuse, SpeedLyser and Pulse Spray under the thrombus portfolio. On the flipside, the company’s Peripheral Vascular business segment witnessed a downside scenario. The company also had a high outstanding debt level at the end of the second quarter. AngioDynamics recalled the Acculis Microwave Tissue Ablation System under the Oncology and Surgery segment recently. Furthermore, AngioDynamics traded below the broader industry in the past year." (1/8/2018)
  • 2. Cantor Fitzgerald analysts commented, "F3Q17 Result Summary. F3Q17 total revenues of $85.6M (down 2.0% y/y), was $3.2M below our estimate of $88.8M and $2.7M below FactSet consensus of $88.3M." (3/30/2017)

Are investors shorting AngioDynamics?

AngioDynamics saw a increase in short interest in December. As of December 15th, there was short interest totalling 1,881,354 shares, an increase of 51.4% from the November 30th total of 1,242,415 shares. Based on an average daily volume of 245,075 shares, the days-to-cover ratio is currently 7.7 days. Approximately 5.2% of the company's shares are short sold.

Who are some of AngioDynamics' key competitors?

Who are AngioDynamics' key executives?

AngioDynamics' management team includes the folowing people:

  • Howard W. Donnelly, Independent Chairman of the Board (Age 56)
  • James C. Clemmer, President, Chief Executive Officer, Director (Age 53)
  • Michael C. Greiner, Chief Financial Officer, Executive Vice President, IR Contact Officer (Age 44)
  • Robert A. Simpson, Senior Vice President and General Manager, Peripheral Vascular (Age 45)
  • Heather J. Daniels-Cariveau, Senior Vice President of Human Resources (Age 43)
  • Gary Barrett, Senior Vice President,Quality and Regulatory Affairs (Age 47)
  • Chad T. Campbell, Senior Vice President and General Manager, Vascular Access (Age 46)
  • Benjamin Davis, Senior Vice President, Business Development (Age 52)
  • Barbara A. Kucharczyk, Senior Vice President-Global Operations (Age 44)
  • Warren G. Nighan, Senior Vice President-Senior Vice President Quality & Regulatory Affairs (Age 48)

Who owns AngioDynamics stock?

AngioDynamics' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Thomson Horstmann & Bryant Inc. (1.01%), Convergence Investment Partners LLC (0.24%) and Bank of Montreal Can (0.16%). Company insiders that own AngioDynamics stock include Avista Capital Partners Gp, Ll, Charles R Greiner, David F Burgstahler, James C Clemmer, Jan Stern Reed and Stephen A Trowbridge. View Institutional Ownership Trends for AngioDynamics.

Who sold AngioDynamics stock? Who is selling AngioDynamics stock?

AngioDynamics' stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can and Convergence Investment Partners LLC. View Insider Buying and Selling for AngioDynamics.

Who bought AngioDynamics stock? Who is buying AngioDynamics stock?

AngioDynamics' stock was bought by a variety of institutional investors in the last quarter, including Thomson Horstmann & Bryant Inc.. Company insiders that have bought AngioDynamics stock in the last two years include James C Clemmer and Jan Stern Reed. View Insider Buying and Selling for AngioDynamics.

How do I buy AngioDynamics stock?

Shares of AngioDynamics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AngioDynamics' stock price today?

One share of AngioDynamics stock can currently be purchased for approximately $16.46.

How big of a company is AngioDynamics?

AngioDynamics has a market capitalization of $600.79 million and generates $349.64 million in revenue each year. The medical instruments supplier earns $5 million in net income (profit) each year or ($0.21) on an earnings per share basis. AngioDynamics employs 1,250 workers across the globe.

How can I contact AngioDynamics?

AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The medical instruments supplier can be reached via phone at 518-795-1400 or via email at [email protected]


MarketBeat Community Rating for AngioDynamics (ANGO)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  134 (Vote Outperform)
Underperform Votes:  215 (Vote Underperform)
Total Votes:  349
MarketBeat's community ratings are surveys of what our community members think about AngioDynamics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

AngioDynamics (NASDAQ:ANGO) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.202.402.402.60
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $18.50$18.50$18.50$18.40
Price Target Upside: 17.76% upside8.63% upside8.63% upside21.69% upside

AngioDynamics (NASDAQ:ANGO) Consensus Price Target History

Price Target History for AngioDynamics (NASDAQ:ANGO)

AngioDynamics (NASDAQ:ANGO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/5/2018Craig HallumDowngradeBuy -> HoldHighView Rating Details
10/8/2017Canaccord GenuityReiterated RatingHold$17.00N/AView Rating Details
9/29/2017KeyCorpReiterated RatingHoldHighView Rating Details
7/19/2017BarclaysLower Price TargetEqual Weight$17.00 -> $16.00LowView Rating Details
7/4/2017Cantor FitzgeraldBoost Price TargetOverweight$20.00 -> $21.00LowView Rating Details
4/8/2016Piper Jaffray CompaniesInitiated CoverageNeutral$12.00N/AView Rating Details
(Data available from 1/17/2016 forward)

Earnings

AngioDynamics (NASDAQ:ANGO) Earnings History and Estimates Chart

Earnings by Quarter for AngioDynamics (NASDAQ:ANGO)

AngioDynamics (NASDAQ ANGO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/28/2018$0.19N/AView Earnings Details
1/4/2018Q2 2018$0.16$0.16$88.15 million$86.70 millionViewListenView Earnings Details
9/28/2017Q1 2018$0.16$0.12$86.12 million$85.40 millionViewN/AView Earnings Details
7/18/2017Q4 2017$0.16$0.19$90.72 million$86.90 millionViewN/AView Earnings Details
3/30/2017Q3 2017$0.15$0.19$88.29 million$85.60 millionViewN/AView Earnings Details
1/6/2017Q217$0.16$0.19$91.09 million$89.00 millionViewListenView Earnings Details
10/5/2016Q117$0.13$0.17$86.09 million$88.10 millionViewN/AView Earnings Details
7/13/2016Q416$0.16$0.19$88.64 million$93.40 millionViewListenView Earnings Details
4/7/2016Q3$0.14$0.15$85.43 million$87.40 millionViewListenView Earnings Details
1/7/2016Q216$0.14$0.14$88.67 million$89.20 millionViewN/AView Earnings Details
10/8/2015Q116$0.11$0.11$84.70 million$83.70 millionViewN/AView Earnings Details
7/16/2015Q415$0.14$0.14$91.67 million$90.90 millionViewListenView Earnings Details
4/9/2015Q315$0.15$0.12$88.69 million$86.60 millionViewN/AView Earnings Details
1/8/2015Q215$0.15$0.17$90.90 million$92.10 millionViewN/AView Earnings Details
10/9/2014Q115$0.11$0.16$85.35 million$87.30 millionViewListenView Earnings Details
7/23/2014Q414$0.12$0.18$93.65 million$94.07 millionViewListenView Earnings Details
4/9/2014Q314$0.09$0.16$86.85 million$88.20 millionViewListenView Earnings Details
1/9/2014Q2$0.07$0.14$87.54 million$88.60 millionViewListenView Earnings Details
10/10/2013Q114$0.03$0.04$82.54 million$83.60 millionViewN/AView Earnings Details
7/11/2013Q4 2013$0.06$0.07$86.43 million$90.00 millionViewN/AView Earnings Details
4/8/2013Q3 2013$0.05$0.08$81.70 million$81.60 millionViewN/AView Earnings Details
1/3/2013Q2 2013$0.09$0.10$87.40 million$87.00 millionViewN/AView Earnings Details
10/8/2012Q113$0.09$0.10$84.35 million$83.40 millionViewN/AView Earnings Details
7/12/2012$0.08$0.09ViewN/AView Earnings Details
4/4/2012$0.07$0.09ViewN/AView Earnings Details
1/5/2012$0.12$0.13ViewN/AView Earnings Details
10/6/2011$0.09$0.08ViewN/AView Earnings Details
7/14/2011$0.10$0.11ViewN/AView Earnings Details
4/5/2011$0.12$0.15ViewN/AView Earnings Details
1/4/2011$0.12$0.13ViewN/AView Earnings Details
10/7/2010Q1 2011$0.08$0.08ViewN/AView Earnings Details
7/15/2010Q4 2010$0.13$0.15ViewN/AView Earnings Details
3/31/2010Q3 2010$0.12$0.13ViewN/AView Earnings Details
1/5/2010Q2 2010$0.11$0.13ViewN/AView Earnings Details
10/6/2009Q1 2010$0.08$0.09ViewN/AView Earnings Details
7/16/2009Q4 2009$0.15$0.14ViewN/AView Earnings Details
4/2/2009Q3 2009$0.12$0.15ViewN/AView Earnings Details
1/6/2009Q2 2009$0.12$0.12ViewN/AView Earnings Details
10/2/2008Q1 2009$0.11$0.09ViewN/AView Earnings Details
7/24/2008Q4 2008$0.17$0.20ViewN/AView Earnings Details
4/2/2008Q3 2008$0.13$0.14ViewN/AView Earnings Details
1/3/2008Q2 2008$0.13$0.13ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

AngioDynamics (NASDAQ:ANGO) Earnings Estimates

2018 EPS Consensus Estimate: $0.74
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.14$0.18$0.16
Q2 20182$0.15$0.16$0.16
Q3 20182$0.20$0.23$0.22
Q4 20182$0.15$0.26$0.21
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for AngioDynamics (NASDAQ:ANGO)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

AngioDynamics (NASDAQ ANGO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.80%
Institutional Ownership Percentage: 95.16%
Insider Trades by Quarter for AngioDynamics (NASDAQ:ANGO)
Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

AngioDynamics (NASDAQ ANGO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/24/2017Jan Stern ReedDirectorBuy316$16.00$5,056.00316View SEC Filing  
7/21/2017James C ClemmerCEOBuy5,000$15.79$78,950.0086,683View SEC Filing  
7/20/2017James C ClemmerCEOBuy20,000$15.64$312,800.0086,683View SEC Filing  
4/12/2017Avista Capital Partners Gp, LlMajor ShareholderSell2,350,000$16.00$37,600,000.00View SEC Filing  
8/5/2016Avista Capital Partners Gp, LlMajor ShareholderSell2,241,000$14.62$32,763,420.00View SEC Filing  
8/5/2016David F BurgstahlerDirectorSell2,250,000$14.62$32,895,000.0023,988View SEC Filing  
5/6/2016Charles R GreinerVPSell3,508$12.31$43,183.4820,910View SEC Filing  
4/25/2016Stephen A TrowbridgeSVPSell12,940$12.30$159,162.0032,469View SEC Filing  
4/14/2014Matthew KapustaSVPBuy1,000$13.90$13,900.0027,005View SEC Filing  
10/18/2013Vincent BucciDirectorBuy5,000$15.20$76,000.00View SEC Filing  
10/17/2013Howard W DonnellyDirectorSell20,000$15.06$301,200.00View SEC Filing  
7/22/2013Kevin J GouldDirectorBuy2,700$12.00$32,400.00View SEC Filing  
5/9/2013Charles R GreinerVPSell1,495$10.38$15,518.10View SEC Filing  
3/12/2013Vincent BucciDirectorBuy85,000$10.77$915,450.00View SEC Filing  
2/14/2013Vincent BucciDirectorBuy2,000$12.17$24,340.00View SEC Filing  
1/11/2013Kevin J GouldDirectorBuy2,700$11.58$31,266.00View SEC Filing  
11/5/2012Jeffrey GoldDirectorBuy1,000$10.56$10,560.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

AngioDynamics (NASDAQ ANGO) News Headlines

Source:
DateHeadline
 Analysts Expect AngioDynamics, Inc. (ANGO) Will Post Quarterly Sales of $86.13 Million Analysts Expect AngioDynamics, Inc. (ANGO) Will Post Quarterly Sales of $86.13 Million
www.americanbankingnews.com - January 16 at 5:56 AM
Zacks: Analysts Anticipate AngioDynamics, Inc. (ANGO) Will Announce Earnings of $0.19 Per ShareZacks: Analysts Anticipate AngioDynamics, Inc. (ANGO) Will Announce Earnings of $0.19 Per Share
www.americanbankingnews.com - January 14 at 7:28 PM
AngioDynamics, Inc. (ANGO) Receives Average Recommendation of "Hold" from AnalystsAngioDynamics, Inc. (ANGO) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - January 9 at 10:22 PM
Q3 2018 EPS Estimates for AngioDynamics, Inc. (ANGO) Increased by AnalystQ3 2018 EPS Estimates for AngioDynamics, Inc. (ANGO) Increased by Analyst
www.americanbankingnews.com - January 8 at 7:12 AM
AngioDynamics (ANGO) Downgraded by BidaskClubAngioDynamics (ANGO) Downgraded by BidaskClub
www.americanbankingnews.com - January 6 at 8:52 PM
AngioDynamics (ANGO) Misses on Earnings, Revenues in Q2AngioDynamics (ANGO) Misses on Earnings, Revenues in Q2
www.zacks.com - January 5 at 3:44 PM
Edited Transcript of ANGO earnings conference call or presentation 4-Jan-18 1:00pm GMTEdited Transcript of ANGO earnings conference call or presentation 4-Jan-18 1:00pm GMT
finance.yahoo.com - January 5 at 12:17 PM
AngioDynamics (ANGO) Downgraded to "Hold" at Craig HallumAngioDynamics (ANGO) Downgraded to "Hold" at Craig Hallum
www.americanbankingnews.com - January 5 at 7:28 AM
AngioDynamics Reports Fiscal 2018 Second Quarter Financial ResultsAngioDynamics Reports Fiscal 2018 Second Quarter Financial Results
finance.yahoo.com - January 4 at 11:10 AM
AngioDynamics misses Street 2Q forecastsAngioDynamics misses Street 2Q forecasts
finance.yahoo.com - January 4 at 11:10 AM
AngioDynamics (ANGO) Releases  Earnings ResultsAngioDynamics (ANGO) Releases Earnings Results
www.americanbankingnews.com - January 4 at 9:02 AM
AngioDynamics, Inc. (ANGO) Sees Large Growth in Short InterestAngioDynamics, Inc. (ANGO) Sees Large Growth in Short Interest
www.americanbankingnews.com - December 31 at 5:04 AM
 Brokerages Expect AngioDynamics, Inc. (ANGO) Will Announce Quarterly Sales of $87.80 Million Brokerages Expect AngioDynamics, Inc. (ANGO) Will Announce Quarterly Sales of $87.80 Million
www.americanbankingnews.com - December 30 at 2:22 AM
Zacks: Brokerages Expect AngioDynamics, Inc. (ANGO) to Announce $0.17 Earnings Per ShareZacks: Brokerages Expect AngioDynamics, Inc. (ANGO) to Announce $0.17 Earnings Per Share
www.americanbankingnews.com - December 28 at 11:32 PM
ETFs with exposure to AngioDynamics, Inc. : December 28, 2017ETFs with exposure to AngioDynamics, Inc. : December 28, 2017
finance.yahoo.com - December 28 at 4:25 PM
AngioDynamics (ANGO) Set to Announce Earnings on ThursdayAngioDynamics (ANGO) Set to Announce Earnings on Thursday
www.americanbankingnews.com - December 28 at 1:20 AM
AngioDynamics to Present at the J.P. Morgan Healthcare ConferenceAngioDynamics to Present at the J.P. Morgan Healthcare Conference
finance.yahoo.com - December 20 at 11:23 AM
AngioDynamics, Inc. (ANGO) Receives Consensus Recommendation of "Hold" from AnalystsAngioDynamics, Inc. (ANGO) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - December 15 at 5:26 PM
AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 15, 2017AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 15, 2017
finance.yahoo.com - December 15 at 11:50 AM
AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018
finance.yahoo.com - December 12 at 11:59 AM
$0.17 EPS Expected for AngioDynamics, Inc. (ANGO) This Quarter$0.17 EPS Expected for AngioDynamics, Inc. (ANGO) This Quarter
www.americanbankingnews.com - December 11 at 7:14 PM
AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 5, 2017AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 5, 2017
finance.yahoo.com - December 5 at 12:59 PM
 Brokerages Anticipate AngioDynamics, Inc. (ANGO) Will Announce Quarterly Sales of $87.80 Million Brokerages Anticipate AngioDynamics, Inc. (ANGO) Will Announce Quarterly Sales of $87.80 Million
www.americanbankingnews.com - November 25 at 2:14 AM
AngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : November 24, 2017AngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : November 24, 2017
finance.yahoo.com - November 24 at 11:44 AM
Zacks: Brokerages Expect AngioDynamics, Inc. (ANGO) Will Post Earnings of $0.17 Per ShareZacks: Brokerages Expect AngioDynamics, Inc. (ANGO) Will Post Earnings of $0.17 Per Share
www.americanbankingnews.com - November 23 at 11:16 PM
AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 22, 2017AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 22, 2017
finance.yahoo.com - November 22 at 4:27 PM
AngioDynamics, Inc. (ANGO) Given Consensus Recommendation of "Hold" by BrokeragesAngioDynamics, Inc. (ANGO) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 20 at 5:44 PM
$88.61 Million in Sales Expected for AngioDynamics, Inc. (ANGO) This Quarter$88.61 Million in Sales Expected for AngioDynamics, Inc. (ANGO) This Quarter
www.americanbankingnews.com - November 6 at 2:32 AM
Why Is AngioDynamics (ANGO) Up 5.3% Since the Last Earnings Report?Why Is AngioDynamics (ANGO) Up 5.3% Since the Last Earnings Report?
finance.yahoo.com - October 30 at 4:48 PM
ETFs with exposure to AngioDynamics, Inc. : October 27, 2017ETFs with exposure to AngioDynamics, Inc. : October 27, 2017
finance.yahoo.com - October 27 at 6:06 PM
AngioDynamics, Inc. (ANGO) Receives Consensus Rating of "Hold" from BrokeragesAngioDynamics, Inc. (ANGO) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - October 26 at 9:38 PM
AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : October 17, 2017AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : October 17, 2017
finance.yahoo.com - October 17 at 4:43 PM
 Analysts Anticipate AngioDynamics, Inc. (ANGO) to Announce $0.17 Earnings Per Share Analysts Anticipate AngioDynamics, Inc. (ANGO) to Announce $0.17 Earnings Per Share
www.americanbankingnews.com - October 16 at 6:24 AM
AngioDynamics, Inc. (ANGO) Earns "Hold" Rating from Canaccord GenuityAngioDynamics, Inc. (ANGO) Earns "Hold" Rating from Canaccord Genuity
www.americanbankingnews.com - October 9 at 3:16 PM
Earnings Review and Free Research Report: Lakeland’s Revenue Jumped 7.4%; EPS Surged 25%Earnings Review and Free Research Report: Lakeland’s Revenue Jumped 7.4%; EPS Surged 25%
finance.yahoo.com - October 4 at 2:21 PM
AngioDynamicis' (ANGO) Solero MTA System to Drive GrowthAngioDynamicis' (ANGO) Solero MTA System to Drive Growth
finance.yahoo.com - October 4 at 2:21 PM
ETFs with exposure to AngioDynamics, Inc. : October 4, 2017ETFs with exposure to AngioDynamics, Inc. : October 4, 2017
finance.yahoo.com - October 4 at 2:21 PM
AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 3, 2017AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 3, 2017
finance.yahoo.com - October 3 at 3:39 PM
AngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : October 2, 2017AngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : October 2, 2017
finance.yahoo.com - October 2 at 3:46 PM
Research Analysts Set Expectations for AngioDynamics, Inc.s Q2 2018 Earnings (ANGO)Research Analysts Set Expectations for AngioDynamics, Inc.'s Q2 2018 Earnings (ANGO)
www.americanbankingnews.com - October 2 at 6:52 AM
AngioDynamics, Inc. (ANGO) Given Average Rating of "Hold" by AnalystsAngioDynamics, Inc. (ANGO) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - October 1 at 7:16 PM
AngioDynamics, Inc. (ANGO) Receives Hold Rating from KeyCorpAngioDynamics, Inc. (ANGO) Receives Hold Rating from KeyCorp
www.americanbankingnews.com - September 29 at 11:08 PM
AngioDynamics, Inc. (ANGO) Posts  Earnings Results, Misses Expectations By $0.04 EPSAngioDynamics, Inc. (ANGO) Posts Earnings Results, Misses Expectations By $0.04 EPS
www.americanbankingnews.com - September 29 at 8:06 AM
Mid-Afternoon Market Update: AngioDynamics Drops On Earnings Miss; Zynerba Pharmaceuticals Shares Spike HigherMid-Afternoon Market Update: AngioDynamics Drops On Earnings Miss; Zynerba Pharmaceuticals Shares Spike Higher
www.benzinga.com - September 28 at 9:28 PM
AngioDynamics misses Street 1Q forecastsAngioDynamics misses Street 1Q forecasts
finance.yahoo.com - September 28 at 12:51 PM
AngioDynamics, Inc. (ANGO) Issues FY18 Earnings GuidanceAngioDynamics, Inc. (ANGO) Issues FY18 Earnings Guidance
www.americanbankingnews.com - September 28 at 9:06 AM
AngioDynamics Reports Fiscal 2018 First Quarter ResultsAngioDynamics Reports Fiscal 2018 First Quarter Results
feeds.benzinga.com - September 28 at 6:59 AM
AngioDynamics misses by $0.04, misses on revenueAngioDynamics misses by $0.04, misses on revenue
seekingalpha.com - September 28 at 6:08 AM
AngioDynamics, Inc. (ANGO) Scheduled to Post Quarterly Earnings on TuesdayAngioDynamics, Inc. (ANGO) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - September 26 at 1:20 AM
AngioDynamics BioFlo Platform Strong, Debt Levels HighAngioDynamics' BioFlo Platform Strong, Debt Levels High
finance.yahoo.com - September 18 at 4:18 PM

SEC Filings

AngioDynamics (NASDAQ:ANGO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

AngioDynamics (NASDAQ:ANGO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

AngioDynamics (NASDAQ ANGO) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.